We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Vaccine Trial Halted After Encephalitis Case
Merck Vaccine Trial Halted After Encephalitis Case
March 31, 2010
Merck Serono, a division of Merck KGaA, has suspended enrollment and treatment of patients in ongoing worldwide studies of its therapeutic vaccine Stimuvax,
following a suspected unexpected serious adverse event (SUSAR).